SCOPUS 정보 검색 플랫폼

Journal of the American Academy of Nurse Practitioners

Volumn 23, Issue 2, 2011, Pages 61-66

Overweight and obesity: Pharmacotherapeutic considerations

(3) Balkon, Nancy a Balkon, Craig b Zitkus, Bruce S a

a Stony Brook School of Dental Medicine (United States)

b Rite Aid (United States)

Author keywords

Obesity; Pharmacology; Pharmacotherapy; Weight management

Indexed keywords

ANOREXIGENIC AGENT; ANTIOBESITY AGENT;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; DRUG EFFECT; HUMAN; NURSING; OBESITY; PATIENT EDUCATION; RISK FACTOR; SEX DIFFERENCE; UNITED STATES; WEIGHT REDUCTION;

ADULT; ANTI-OBESITY AGENTS; APPETITE DEPRESSANTS; BODY MASS INDEX; BODY WEIGHT; CHILD; HUMANS; OBESITY; OVERWEIGHT; PATIENT EDUCATION AS TOPIC; RISK FACTORS; SEX FACTORS; UNITED STATES; WEIGHT LOSS;

EID: 79551482912 PISSN: 10412972 EISSN: 17457599 Source Type: Journal
DOI: 10.1111/j.1745-7599.2010.00587.x Document Type: Article

Times cited : (4)

References (7)

1
- 79551477348
- Clinicaltrials.gov. A long term study of sibutramine and the role of obesity management in relation to cardiovascular disease in overweight and obese patients (SCOUT). Last updated May 6, 2010. Study completed November 2009.
- Clinicaltrials.gov. 2010. A long term study of sibutramine and the role of obesity management in relation to cardiovascular disease in overweight and obese patients (SCOUT). Last updated May 6, 2010. Study completed November 2009.
- (2010)

2
- 77956284607
- SCOUT Investigators. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects
- James, W. P., Caterson, I. D., Coutinho, W., Finer, N., Van Gaal, L. F., Maggioni, A. P., et al. (2010). SCOUT Investigators. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. New England Journal of Medicine, 363(10):905-917.
- (2010) New England Journal of Medicine , vol.363 , Issue.10 , pp. 905-917
- James, W.P.¹ Caterson, I.D.² Coutinho, W.³ Finer, N.⁴ Van Gaal, L.F.⁵ Maggioni, A.P.⁶

3
- 0011809536
- Pharmacology: Drug therapy and nursing considerations
- Philadelphia J. B. Lippincott.
- Malseed, R. T., Goldstein, F. J., & Balkon, N. B. (1994). Pharmacology: Drug therapy and nursing considerations (pp. 3-11). Philadelphia J. B. Lippincott.
- (1994) , pp. 3-11
- Malseed, R.T.¹ Goldstein, F.J.² Balkon, N.B.³

4
- 79551479148
- Vital signs: State-Specific obesity prevalence among adults - United States, 2009. Morbidity and Mortality Weekly Reviews, August 3, 2010 Retrieved October 2010 from
- Sherry, B., Blanck, H. M., Galuska, D. A., Pan, L., Dietz, H. W., & Balluz, L. (2010). Vital signs: State-Specific obesity prevalence among adults - United States, 2009. Morbidity and Mortality Weekly Reviews, August 3, 2010 Retrieved October 2010 from
- (2010)
- Sherry, B.¹ Blanck, H.M.² Galuska, D.A.³ Pan, L.⁴ Dietz, H.W.⁵ Balluz, L.⁶

5
- 79551501157
- U.S. Food and Drug Administration Postmarket drug safety information-- Fen-Phen. Retrieved October 2010 from
- U.S. Food and Drug Administration. (2010a). Postmarket drug safety information-- Fen-Phen. Retrieved October 2010 from
- (2010)

6
- 79551482874
- U.S. Food and Drug Administration Postmarket drug safety information - Meridia. Retrieved October 2010 from
- U.S. Food and Drug Administration. (2010b). Postmarket drug safety information - Meridia. Retrieved October 2010 from
- (2010)

7
- 79551475269
- U.S. Food and Drug Administration Safety information - Orlistat. Retrieved October 2010 from
- U.S. Food and Drug Administration. (2010c). Safety information - Orlistat. Retrieved October 2010 from
- (2010)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.